Literature DB >> 26297865

Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder.

Rafael T de Sousa1, Emilio L Streck2, Orestes V Forlenza3, Andre R Brunoni3, Marcus V Zanetti4, Gabriela K Ferreira2, Breno S Diniz5, Luis V Portela6, André F Carvalho7, Carlos A Zarate8, Wagner F Gattaz3, Rodrigo Machado-Vieira9.   

Abstract

Several lines of evidence suggest a role for mitochondrial dysfunction in the pathophysiology of bipolar disorder (BD). The tricarboxylic acid cycle (TCA cycle) is fundamental for mitochondrial energy production and produces substrates used in oxidative phosphorylation by the mitochondrial electron transport chain. The activity of the key TCA cycle enzymes citrate synthase, malate dehydrogenase, and succinate dehydrogenase has never been evaluated in BD. In the present study, these enzymes were assayed from leukocytes of drug-naïve BD patients in a major depressive episode (n=18) and compared to 24 age-matched healthy controls. Drug-naïve BD patients did not show differences in activities of citrate synthase (p=0.79), malate dehydrogenase (p=0.17), and succinate dehydrogenase (p=0.35) compared with healthy controls. No correlation between any TCA cycle enzyme activity and severity of depressive symptoms was observed. Overall, these data suggest that the activities of the TCA cycle enzymes are not altered in major depressive episodes of recent-onset BD, which may support the concept of illness staging and neuroprogression in BD. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Bioenergetics; Bipolar disorder; Depression; Mitochondria; Pathophysiology; Tricarboxylic acid cycle

Mesh:

Year:  2015        PMID: 26297865      PMCID: PMC5116385          DOI: 10.1016/j.neulet.2015.08.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

Review 1.  Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Authors:  Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-02       Impact factor: 4.132

2.  Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

Authors:  Ana C Andreazza; Li Shao; Jun-Feng Wang; L Trevor Young
Journal:  Arch Gen Psychiatry       Date:  2010-04

3.  Effects of tamoxifen on tricarboxylic acid cycle enzymes in the brain of rats submitted to an animal model of mania induced by amphetamine.

Authors:  Samira S Valvassori; Daniela V Bavaresco; Josiane Budni; Tamara S Bobsin; Cinara L Gonçalves; Karolina V de Freitas; Emilio L Streck; João Quevedo
Journal:  Psychiatry Res       Date:  2013-11-21       Impact factor: 3.222

4.  Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine.

Authors:  Gustavo Feier; Samira S Valvassori; Roger B Varela; Wilson R Resende; Daniela V Bavaresco; Meline O Morais; Giselli Scaini; Monica L Andersen; Emilio L Streck; João Quevedo
Journal:  Pharmacol Biochem Behav       Date:  2012-09-23       Impact factor: 3.533

5.  The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies.

Authors:  Kayode S Oyedotun; Bernard D Lemire
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

Review 6.  Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

Authors:  Rafael T de Sousa; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Ther Targets       Date:  2014-07-24       Impact factor: 6.902

7.  Isolation, nucleotide sequence analysis, and disruption of the MDH2 gene from Saccharomyces cerevisiae: evidence for three isozymes of yeast malate dehydrogenase.

Authors:  K I Minard; L McAlister-Henn
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

Review 8.  Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena.

Authors:  Robert M Post
Journal:  Neurosci Biobehav Rev       Date:  2007-04-24       Impact factor: 8.989

9.  Leukocyte mitochondrial DNA copy number in bipolar disorder.

Authors:  Rafael T de Sousa; Miyuki Uno; Marcus V Zanetti; Sueli M O Shinjo; Geraldo F Busatto; Wagner F Gattaz; Sueli K N Marie; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-09-13       Impact factor: 5.067

10.  Is human blood a good surrogate for brain tissue in transcriptional studies?

Authors:  Chaochao Cai; Peter Langfelder; Tova F Fuller; Michael C Oldham; Rui Luo; Leonard H van den Berg; Roel A Ophoff; Steve Horvath
Journal:  BMC Genomics       Date:  2010-10-20       Impact factor: 3.969

View more
  4 in total

Review 1.  Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder.

Authors:  Luiz Arthur Rangel Cyrino; Daniela Delwing-de Lima; Oliver Matheus Ullmann; Thayná Patachini Maia
Journal:  Front Behav Neurosci       Date:  2021-02-26       Impact factor: 3.558

2.  Exploration on the Enhancement of Detoxification Ability of Zearalenone and Its Degradation Products of Aspergillus niger FS10 under Directional Stress of Zearalenone.

Authors:  Jian Ji; Jian Yu; Yang Yang; Xiao Yuan; Jia Yang; Yinzhi Zhang; Jiadi Sun; Xiulan Sun
Journal:  Toxins (Basel)       Date:  2021-10-12       Impact factor: 4.546

Review 3.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

4.  Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder.

Authors:  Martina Zvěřová; Jana Hroudová; Zdeněk Fišar; Hana Hansíková; Lucie Kališová; Eva Kitzlerová; Alena Lambertová; Jiří Raboch
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-14       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.